Living near harmful algal blooms reduces life expectancy with ALS

Researchers say avoiding these toxic blooms may reduce the rate of disease

5:00 AM

Author | Noah Fromson

algae green spread all over lake by forest edge from high view
Getty Images

Living close to cyanobacterial harmful algal blooms — which are present nationwide but are more common in coastal and Great Lakes states — heightens the rate of dying from amyotrophic lateral sclerosis, or ALS, a study suggests.

These blooms occur when cyanobacteria, also called blue-green algae, grows dense and out of control, producing toxic agents that can poison people and the environment. 

Researchers at Michigan Medicine surveyed participants with ALS who were seen at the University of Michigan Pranger ALS Clinic.

Investigators measured the duration and extent of each participant’s exposure to cyanobacterial harmful algal blooms by compiling their residential and health histories, as well as satellite data from the Cyanobacteria Assessment Network.

Many participants lived within three miles of a harmful algal bloom. Living near blooms, especially if swimming, boating or using a local and possibly contaminated water source, was associated with dying of ALS nearly one year sooner.

The results are published in the International Journal of Environmental Research and Public Health.

“Harmful algal blooms are a growing problem across the country, and it is not uncommon for people to live near them,” said senior author Stephen Goutman, M.D., Harriet Hiller Research Professor, director of the Pranger ALS Clinic and associate director of the ALS Center of Excellence at University of Michigan.

“Our study shows a clear link between living in close proximity to cyanobacteria blooms over the course of one’s life and adverse outcomes of ALS.”

People may be exposed to cyanobacteria toxins through ingestion, inhalation and contact with the skin from several activities, such as swimming and fishing.

In the study, people with the most significant exposures both lived near harmful blooms and used a private well as their water source.

Cyanobacteria produce several toxic agents that are linked neurodegenerative diseases, including ALS, Alzheimer’s and Parkinson’s. 

One such toxin, called ß-methylamino-L-alanine, has been detected in brain and cerebral spinal fluid samples of participants with ALS.

“While there is still limited research into the mechanism by which cyanobacteria toxins affect neurodegenerative diseases, our findings suggest that living near or participating in activities in these water bodies may influence the progression of ALS,” Goutman said.

ALS is in part influenced by genetics, but the disease is also largely driven by environmental factors.

The accumulation of exposures to toxins and pollutants, such as pesticides and volatile organic compounds, is known as the ALS exposome.

In the United States, cases of ALS are highest in the Midwest.

Researchers believe that is in part due to pervasive industrial and agricultural productions in the region.

“If exposure to cyanobacteria toxins is a meaningful risk factor for ALS, the large number of inland lakes prone to such bacteria in the Midwest may partly explain why the disease incidence is much higher than other parts of the country,” said Stuart Batterman, Ph.D., first author and professor of environmental health sciences at the U-M School of Public Health.

“Given the complexity of ALS, we must maintain an epidemiological approach that encompasses environmental exposures over the life course. These studies provide will continue to provide insight into risk facts associated with disease onset and the effects on survival.”

Additional authors: Md Kamrul Islam, M.S., Dae Gyu Jang, Ph.D., and Eva L. Feldman, M.D., Ph.D., all of University of Michigan.

Funding/disclosures: This study was supported by the National Institute of Neurological Disorders and Stroke (NS127188), and the National Institute of Environmental Health Sciences (ES027221, ES030049, ES017885) of the National Institutes of Health.

It was also supported by the Centers for Disease Control and Prevention (TS000344).

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the CDC.

Additional support from the Scott L. Pranger ALS Clinic Fund, the NeuroNetwork for Emerging Therapies, the Andrea and Lawrence Wolfe Brain Health Initiative, the Robert and Katherine Jacobs Environmental Health Initiative Fund and the Coleman Therapeutic Discovery Fund.

Paper cited: “Life Course Exposure to Cyanobacteria and Amyotrophic Lateral Sclerosis Survival,” International Journal of Environmental Research and Public Health. DOI: 10.3390/ijerph22050763

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

Lou Gehrig's (ALS) Neurological (Brain) Conditions Neurodegenerative Disorder All Research Topics Emerging Technologies
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

goutman

Stephen A Goutman, MD, MS, FAAN

Associate Professor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

presentation on stage with slideshow up
Health Lab

Medical students develop novel technological solutions for unmet patient needs

University of Michigan medical students showcased AI-driven healthcare innovation projects focused on melanoma support, transplant recovery and primary care access.
Girl with Down syndrome sleeping in bed
Health Lab

Treating obstructive sleep apnea in children with Down syndrome

Sleep experts discuss why early treatment matters, the limitations of current therapies, and research opportunities to improve treatment of obstructive sleep apnea in children with Down syndrome.
small bacteria cells floating on blue background reddish tint
Health Lab

Study overturns 100-year-old assumption about common bacteria in the lungs

A new U-M study overturns a 100-year-old assumption about one common bacterial resident of the lungs, Prevotella melaninogenica.
pill in child's hand blue sweater
Health Lab

More leucovorin prescribed to kids after federal officials touted its unproven benefits for autism

A new study finds sharp increase in dispensing of leucovorin after high profile news conference touting its unproven benefits for autism.
woman on phone taking notes
Health Lab

7 things every family caregiver should know – but many don’t

A guide to many community resource, and state and federal programs, that University of Michigan polls show caregivers to older adults and people with disabilities often don’t know about.
cancer cell floating with yellow dots drawn out blue
Health Lab

Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy

The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study by Michigan Medicine.